文献速递术前评估与围术期医学气道管理

术后前3天低氧血症与1年死亡率增加相关

Hypoxemia Within the First 3 Postoperative Days Is Associated With Increased 1-Year Postoperative Mortality After Adjusting for Perioperative Opioids and Other Confounders.
PubMed 文献 · Anesth Analg · 2020-01-01

围术期阿片类药物用量与1年死亡率无独立关联。

要点

  • 术后前3天SpO2≤85%事件发生率为24.9%,与1年死亡率独立相关。
  • 每增加10%的低氧读数频率,1年死亡风险增加20%(OR 1.20)。
  • 围术期阿片用量未独立增加1年死亡率,低氧本身需重视。

核心结论

  • 调整围术期阿片类药物及其他混杂因素后,术后前3天中重度低氧血症与1年术后死亡率独立相关。

研究设计与样本

  • 回顾性队列研究,查询Epic Clarity数据库,纳入2012年1月1日至2016年3月31日期间三家医院(1学术、2社区)成人住院麻醉 encounters,排除同次住院多次手术或再入院者,共43,011例符合标准。

主要发现

  • 10,727例(24.9%)发生至少1次POH事件(PACU转出至POD3期间SpO2≤85%);其中POD1有7,179例(66.9%),POD2有5,340例(49.8%),POD3有3,455例(32.3%)。
  • POH组较无POH组年龄更大、呼吸及其他合并症更多、手术时间更长、手术当日及POD1阿片剂量更高、更常接受连续脉氧监测。
  • POH组术后更常需要氧疗、无创通气、插管和ICU入住。
  • 1年术后死亡率:POH组4.4%,无POH组3.0%(P < .001)。
  • 调整混杂因素后,SpO2≤85%读数频率每增加10%,术后1年死亡 odds 为1.20(95%CI 1.11-1.29;P < .001);围术期阿片类药物未独立增加1年死亡率。

临床怎么用

  • 麻醉科智能体应关注术后前3天SpO2≤85%事件,将其视为1年死亡风险增加的警示信号。
  • 围术期阿片管理之外,需重视术后低氧的监测与干预,但降低低氧能否改善结局尚待研究。

局限性

  • 原文未明确报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative hypoxemia (POH) is common and primarily treated with temporary oxygen supplementation. Because the clinical impact of POH is sometimes presumed as minor, efforts to better understand and minimize it have been limited. Here, we hypothesized that, after adjusting for opioids received perioperatively and other confounders, the frequency of POH events (POH%) reported within the first 3 postoperative days (PODs) is associated with increased postoperative 1-year mortality. METHODS: With prior institutional review board (IRB) approval, the Epic Clarity database was queried for all adult inpatient anesthesia encounters performed at our health system (1 academic and 2 community hospitals) from January 1, 2012 to March 31, 2016. Patients with multiple hospitalizations or subsequent surgeries within the same hospitalization were excluded. We classified patients based on the presence (POH) or not (No-POH) of ≥1 documented peripheral saturation of oxyhemoglobin (SpO2) ≤85% event of any duration occurring between the discharge from the postanesthesia care unit (PACU) until POD 3. Demographics, comorbidities, surgery duration, morphine milligram equivalents (OMME) administered perioperatively, respiratory therapies, intensive care unit (ICU) admission, and hospital length of stay (LOS) were also collected. Logistic regression was used to characterize the association between POH and 1-year postoperative mortality after adjusting for perioperatively administered opioids and other confounding factors. RESULTS: A total of 43,011 patients met study criteria. At least 1 POH event was reported in 10,727 (24.9%) patients. Of these, 7179 (66.9%) had ≥1 hypoxemic event on POD 1, 5340 (49.8%) on POD 2, and 3455 (32.3%) on POD 3. Patients with ≥1 POH event, compared to No-POH patients, were older, had more respiratory and other comorbidities, underwent longer surgeries, received greater opioid doses on the day of surgery and POD 1, and received more continuous pulse oximetry monitoring. POH patients required more frequent postoperative oxygen therapy, noninvasive ventilation (NIV), intubation, and ICU admission. One-year postoperative mortality occurred in 4.4% of patients with ≥1 POH and 3.0% of No-POH patients (P < .001). After adjusting for confounding factors, for every 10% increase in the frequency of SpO2 ≤85% readings, the odds of postoperative 1-year mortality were 1.20 (95% confidence interval [CI], 1.11-1.29; P < .001). Perioperative opioids were not independently associated with increased 1-year mortality. CONCLUSIONS: After adjusting for perioperative opioids and other confounders, moderate/severe POH within the first 3 PODs was independently associated with increased 1-year postoperative mortality. Increased efforts should be directed to understand if efforts to detect and reduce POH lead to improved patient outcomes.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Bartels K, Kaizer A, Jameson L, et al. Hypoxemia Within the First 3 Postoperative Days Is Associated With Increased 1-Year Postoperative Mortality After Adjusting for Perioperative Opioids and Other Confounders. Anesth Analg. 2020. PMID: 31971921. doi:10.1213/ANE.0000000000004553

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。